Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Status unconfirmed · Phase 1

Conditions studied: Amphetamine-Related Disorders

In brief

The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.

Key facts

Study ID

NCT00089440

Run by

National Institute on Drug Abuse (NIDA)

People needed

17

Starts

2004-06-01

Expected to finish

2005-03-01

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must meet DSM-4 criteria for methamphetamine abuse or dependence and are non-treatment seeking.
• Ability to verbalize understanding of the consent form, able to provide written informed consent, and verbalize willingness to complete study procedures.

You may not qualify if…

• Please contact the site for more information.

Where it is running

• UCLA Integrated Substance Abuse Program — Los Angeles, California, United States
• New York University, School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.